Literature DB >> 3741370

Amino acid sequence of the active site of human serum cholinesterase from usual, atypical, and atypical-silent genotypes.

O Lockridge, B N La Du.   

Abstract

Active-site tryptic peptides were isolated from three genetic types of human serum cholinesterase. The active-site peptide was identified by labeling the active-site serine with [3H]diisopropylfluorophosphate. Peptides were purified by high-performance liquid chromatography. Amino acid composition and sequence analysis showed that the peptide from the usual genotype contained 29 residues with the sequence Ser-Val-Thr-Leu-Phe-Gly-Glu-Ser-Ala-Gly-Ala-Ala-Ser-Val-Ser-Leu-His-Leu- Leu-Ser-Pro-Gly-Ser-His-Ser-Leu-Phe-Thr-Arg. The active-site serine was the eighth residue from the N-terminal. The peptide containing the active-site serine from the atypical genotype contained 22 residues with the sequence Ser-Val-Thr-Leu-Phe-Gly-Glu-Ser-Ala-Gly-Ala-Ala-Ser-Val-Ser-Leu-His-Leu- Leu-Ser-Pro-Gly. The peptide from the atypical-silent genotype contained eight residues with the sequence Gly-Glu-Ser-Ala-Gly-Ala-Ala-Ser. Thus, the sequences of the atypical and atypical-silent active-site peptides were identical to the corresponding portions of the usual peptide.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3741370     DOI: 10.1007/bf00499101

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  22 in total

1.  Some statistical data on atypical cholinesterase of human serum.

Authors:  W KALOW; D R GUNN
Journal:  Ann Hum Genet       Date:  1959-07       Impact factor: 1.670

2.  The relation between dose of succinylcholine and duration of apnea in man.

Authors:  W KALOW; D R GUNN
Journal:  J Pharmacol Exp Ther       Date:  1957-06       Impact factor: 4.030

3.  Interchain disulfide bonds and subunit organization in human serum cholinesterase.

Authors:  O Lockridge; H W Eckerson; B N La Du
Journal:  J Biol Chem       Date:  1979-09-10       Impact factor: 5.157

4.  Kinetics of succinyldithiocholine hydrolysis by serum cholinesterase: comparison to dibucaine and succinylcholine numbers.

Authors:  L B Hersh; P P Raj; D Ohlweiler
Journal:  J Pharmacol Exp Ther       Date:  1974-05       Impact factor: 4.030

5.  Reverse-phase high-performance liquid chromatography of hydrophobic proteins and fragments thereof.

Authors:  G E Tarr; J W Crabb
Journal:  Anal Biochem       Date:  1983-05       Impact factor: 3.365

6.  Loss of the interchain disulfide peptide and dissociation of the tetramer following limited proteolysis of native human serum cholinesterase.

Authors:  O Lockridge; B N La Du
Journal:  J Biol Chem       Date:  1982-10-25       Impact factor: 5.157

7.  Simple, rapid, and highly efficient separation of amino acid phenylthiohydantoins by reversed-phase high-performance liquid chromatography.

Authors:  S D Black; M J Coon
Journal:  Anal Biochem       Date:  1982-04       Impact factor: 3.365

8.  Silent cholinesterase gene: variations in the properties of serum enzyme in apparent homozygotes.

Authors:  H M Rubinstein; A A Dietz; L K Hodges; T Lubrano; V Czebotar
Journal:  J Clin Invest       Date:  1970-03       Impact factor: 14.808

9.  Heterogeneity in the silent gene phenotype of psudocholinesterase of human serum.

Authors:  K Altland; H W Goedde
Journal:  Biochem Genet       Date:  1970-04       Impact factor: 1.890

10.  Structural difference at the active site of dibucaine resistant variant of human plasma cholinesterase.

Authors:  H Muensch; A Yoshida; K Altland; W Jensen; H W Goedde
Journal:  Am J Hum Genet       Date:  1978-05       Impact factor: 11.025

View more
  11 in total

Review 1.  Comparison of butyrylcholinesterase and acetylcholinesterase.

Authors:  A Chatonnet; O Lockridge
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

Review 2.  Molecular biological search for human genes encoding cholinesterases.

Authors:  H Soreq; A Gnatt
Journal:  Mol Neurobiol       Date:  1987 Spring-Summer       Impact factor: 5.590

3.  Identification of the structural mutation responsible for the dibucaine-resistant (atypical) variant form of human serum cholinesterase.

Authors:  M C McGuire; C P Nogueira; C F Bartels; H Lightstone; A Hajra; A F Van der Spek; O Lockridge; B N La Du
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

4.  De novo amplification within a "silent" human cholinesterase gene in a family subjected to prolonged exposure to organophosphorous insecticides.

Authors:  C A Prody; P Dreyfus; R Zamir; H Zakut; H Soreq
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

Review 5.  [The development of pharmacogenetics--a retrospective on the 75th birthday of Hans Herken].

Authors:  W Kalow
Journal:  Klin Wochenschr       Date:  1988-03-15

6.  Dichlorvos, chlorpyrifos oxon and Aldicarb adducts of butyrylcholinesterase, detected by mass spectrometry in human plasma following deliberate overdose.

Authors:  Bin Li; Ivan Ricordel; Lawrence M Schopfer; Frédéric Baud; Bruno Mégarbane; Patrick Masson; Oksana Lockridge
Journal:  J Appl Toxicol       Date:  2010-08       Impact factor: 3.446

7.  In vitro sensitivity of cholinesterases and [3H]oxotremorine-M binding in heart and brain of adult and aging rats to organophosphorus anticholinesterases.

Authors:  Nikita Mirajkar; Carey N Pope
Journal:  Biochem Pharmacol       Date:  2008-08-12       Impact factor: 5.858

8.  Tissue-specific processing and polarized compartmentalization of clone-produced cholinesterase in microinjected Xenopus oocytes.

Authors:  P A Dreyfus; S Seidman; M Pincon-Raymond; M Murawsky; F Rieger; E Schejter; H Zakut; H Soreq
Journal:  Cell Mol Neurobiol       Date:  1989-09       Impact factor: 5.046

9.  Isolation of a tripeptide (Ala-Gly-Ser) exhibiting weak acetylthiocholine hydrolyzing activity from a high-salt soluble form of monkey diaphragm acetylcholinesterase.

Authors:  L D Jayanthi; A S Balasubramanian
Journal:  Neurochem Res       Date:  1992-04       Impact factor: 3.996

10.  Cholinoceptive properties of human primordial, preantral, and antral oocytes: in situ hybridization and biochemical evidence for expression of cholinesterase genes.

Authors:  G Malinger; H Zakut; H Soreq
Journal:  J Mol Neurosci       Date:  1989       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.